GENENTA SCIENCE(SP.ADR)/1 (K5F) — Working Capital to Net Assets Ratio
GENENTA SCIENCE(SP.ADR)/1 (K5F) has a Working Capital to Net Assets ratio of 127.6% as of December 2025. Working capital of €27.86 Million (current assets of €29.98 Million minus current liabilities of €2.12 Million) is measured against net assets of €21.84 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See K5F defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GENENTA SCIENCE(SP.ADR)/1 Working Capital to Net Assets (2021–2025)
This chart shows how GENENTA SCIENCE(SP.ADR)/1's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 127.6%, reflecting working capital of €27.86 Million against net assets of €21.84 Million EUR. For the complete balance sheet picture, see balance sheet size of GENENTA SCIENCE(SP.ADR)/1.
Annual Working Capital to Net Assets for GENENTA SCIENCE(SP.ADR)/1 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for GENENTA SCIENCE(SP.ADR)/1 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check GENENTA SCIENCE(SP.ADR)/1 liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 127.6% | €27.86 Million | €21.84 Million | €29.98 Million | €2.12 Million | ▲ +28.5 pp |
| 2024 | 99.0% | €12.37 Million | €12.50 Million | €14.47 Million | €2.10 Million | ▲ +3.5 pp |
| 2023 | 95.5% | €19.52 Million | €20.43 Million | €21.26 Million | €1.74 Million | ▲ +0.7 pp |
| 2022 | 94.9% | €29.54 Million | €31.14 Million | €31.72 Million | €2.18 Million | ▼ -2.0 pp |
| 2021 | 96.8% | €37.62 Million | €38.86 Million | €38.76 Million | €1.14 Million | — |